The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis

Frontiers in Bioscience

Volumn 16, Issue 5, 2011, Pages 1861-1872

  Wagstaff, Laura ^a   Kelwick, Richard ^b   Decock, Julie ^b   Edwards, Dylan R ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

ADAMTS; Angiogenesis; Metalloproteinase; Metastasis; Review; Thrombospondin type 1 repeat

Indexed keywords

ADAM PROTEIN; ANGIOGENESIS INHIBITOR; METALLOPROTEINASE; THROMBOSPONDIN;

ANIMAL; GENETICS; HUMAN; METASTASIS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADAM PROTEINS; ANGIOGENESIS INHIBITORS; ANIMALS; HUMANS; METALLOPROTEASES; NEOPLASM METASTASIS; NEOPLASMS; THROMBOSPONDINS;

EID: 79955027296     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3827     Document Type: Article

References (79)

1. C. E. Brinckerhoff and L. M. Matrisian: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol, 3(3), 207-14 (2002)
2. L. M. Coussens, B. Fingleton and L. M. Matrisian: Matrix Metalloproteinase Inhibitors and Cancer - Trials and Tribulations. Science, 295(5564), 2387-2392 (2002) (Pubitemid 34270240)
3. M. Egeblad and Z. Werb: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2(3), 161-74 (2002) (Pubitemid 37328786)
4. C. Lopez-Otin and L. M. Matrisian: Emerging roles of proteases in tumor suppression. Nat Rev Cancer, 7(10), 800-8 (2007) (Pubitemid 47463671)
5. S. Porter, I. M. Clark, L. Kevorkian and D. R. Edwards: The ADAMTS metalloproteinases. Biochem J, 386(Pt 1), 15-27 (2005)
6. G. C. Jones and G. P. Riley: ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis research & therapy, 7(4), 160-9 (2005) (Pubitemid 40936607)
7. S. S. Apte: A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. The Journal of Biological Chemistry, 284(46), 31493-7 (2009)
8. S. Mochizuki and Y. Okada: ADAMs in cancer cell proliferation and progression. Cancer Sci, 98(5), 621-8 (2007) (Pubitemid 46563436)
9. G. Paulissen, N. Rocks, M. M. Gueders, C. Crahay, F. Quesada-Calvo, S. Bekaert, J. Hacha, M. El Hour, J. M. Foidart, A. Noel and D. D. Cataldo: Role of ADAM and ADAMTS metalloproteinases in airway diseases. Respir Res, 10, 127 (2009)
10. T. Shiomi, V. Lemaitre, J. D'Armiento and Y. Okada: Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int, 60(7), 477-96 (2010)
11. K. Kuno, N. Kanada, E. Nakashima, F. Fujiki, F. Ichimura and K. Matsushima: Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene. The Journal of Biological Chemistry, 272(1), 556-562 (1997) (Pubitemid 27021194)
12. D. R. McCulloch, C. M. Nelson, L. J. Dixon, D. L. Silver, J. D. Wylie, V. Lindner, T. Sasaki, M. A. Cooley, W. S. Argraves and S. S. Apte: ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell, 17(5), 687-98 (2009)
13. K. Stankunas, C. T. Hang, Z. Y. Tsun, H. Chen, N. V. Lee, J. I. Wu, C. Shang, J. H. Bayle, W. Shou, M. L. Iruela-Arispe and C. P. Chang: Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell, 14(2), 298-311 (2008) (Pubitemid 351189176)
14. D. L. Silver, L. Hou, R. Somerville, M. E. Young, S. S. Apte and W. J. Pavan: The secreted metalloprotease ADAMTS20 is required for melanoblast survival. PLoS genetics, 4(2), e1000003-e1000003 (2008)
15. T. Sjoblom, S. Jones, L. D. Wood, D. W. Parsons, J. Lin, T. D. Barber, D. Mandelker, R. J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. Meeh, S. D. Markowitz, J. Willis, D. Dawson, J. K. Willson, A. F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B. H. Park, K. E. Bachman, N. Papadopoulos, B. Vogelstein, K. W. Kinzler and V. E. Velculescu: The consensus coding sequences of human breast and colorectal cancers. Science, 314(5797), 268-74 (2006) (Pubitemid 44571966)
16. A. C. Nicholson, S. B. Malik, J. M. Logsdon, Jr. and E. G. Van Meir: Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organizations. BMC Evol Biol, 5(1), 11 (2005)
17. J. Huxley-Jones, T. K. Clarke, C. Beck, G. Toubaris, D. L. Robertson and R. P. Boot-Handford: The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio. BMC Evol Biol, 7, 63 (2007)
18. S. Gerhardt, G. Hassall, P. Hawtin, E. McCall, L. Flavell, C. Minshull, D. Hargreaves, A. Ting, R. A. Pauptit, A. E. Parker and W. M. Abbott: Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. Journal of molecular biology, 373(4), 891-902 (2007) (Pubitemid 47505246)
19. D. R. Edwards, M. M. Handsley and C. J. Pennington: The ADAM metalloproteinases. Mol Aspects Med, 29(5), 258-89 (2008)
20. K. Kuno and K. Matsushima: ADAMTS-1 Protein Anchors at the Extracellular Matrix through the Thrombospondin Type I Motifs and Its Spacing Region. The Journal of Biological Chemistry, 273(22), 13912-13917 (1998) (Pubitemid 28268445)
21. C. R. Flannery, W. Zeng, C. Corcoran, L. A. Collins-Racie, P. S. Chockalingam, T. Hebert, S. A. Mackie, T. McDonagh, T. K. Crawford, K. N. Tomkinson, E. R. LaVallie and E. A. Morris: Autocatalytic cleavage of ADAMTS-4 (Aggrecanase- 1) reveals multiple glycosaminoglycan-binding sites. J Biol Chem, 277(45), 42775-80 (2002) (Pubitemid 35285651)
22. M. Kashiwagi, J. J. Enghild, C. Gendron, C. Hughes, B. Caterson, Y. Itoh and H. Nagase: Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem, 279(11), 10109-19 (2004) (Pubitemid 38372615)
23. J. C. Rodriguez-Manzaneque, A. B. Milchanowski, E. K. Dufour, R. Leduc and M. L. Iruela-Arispe: Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. The Journal of Biological Chemistry, 275(43), 33471-9 (2000)
24. P. Wang, M. Tortorella, K. England, A. M. Malfait, G. Thomas, E. C. Arner and D. Pei: Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J Biol Chem, 279(15), 15434-40 (2004) (Pubitemid 38618943)
25. B. H. Koo, J. M. Longpre, R. P. Somerville, J. P. Alexander, R. Leduc and S. S. Apte: Regulation of ADAMTS9 secretion and enzymatic activity by its propeptide. J Biol Chem, 282(22), 16146-54 (2007) (Pubitemid 47100362)
26. E. M. Majerus, X. Zheng, E. A. Tuley and J. E. Sadler: Cleavage of the ADAMTS13 propeptide is not required for protease activity. J Biol Chem, 278(47), 46643-8 (2003) (Pubitemid 37452240)
27. J. C. Rodriguez-Manzaneque, J. Westling, S. N. Thai, A. Luque, V. Knauper, G. Murphy, J. D. Sandy and M. L. Iruela-Arispe: ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun, 293(1), 501-8 (2002) (Pubitemid 34694236)
28. G. J. Wayne, S. J. Deng, A. Amour, S. Borman, R. Matico, H. L. Carter and G. Murphy: TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4. J Biol Chem, 282(29), 20991-8 (2007) (Pubitemid 47099922)
29. A. H. Baker, D. R. Edwards and G. Murphy: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Journal of cell science, 115(Pt 19), 3719-27 (2002) (Pubitemid 35203598)
30. N. H. Lim, M. Kashiwagi, R. Visse, J. Jones, J. J. Enghild, K. Brew and H. Nagase: Reactive site mutants of N-TIMP-3that selectively inhibit ADAMTS-4 and ADAMTS-5: Biological and structural implications. Biochem J (2010)
31. S. Porter, S. D. Scott, E. M. Sassoon, M. R. Williams, J. L. Jones, A. C. Girling, R. Y. Ball and D. R. Edwards: Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res, 10(7), 2429-40 (2004) (Pubitemid 38445703)
32. N. Rocks, G. Paulissen, F. Quesada Calvo, M. Polette, M. Gueders, C. Munaut, J. M. Foidart, A. Noel, P. Birembaut and D. Cataldo: Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer, 94(5), 724-730 (2006) (Pubitemid 43361905)
33. A. Stokes, J. Joutsa, R. Ala-Aho, M. Pitchers, C. J. Pennington, C. Martin, D. J. Premachandra, Y. Okada, J. Peltonen, R. Grenman, H. A. James, D. R. Edwards and V. M. Kahari: Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res, 16(7), 2022-35 (2010)
34. K. Demircan, E. Gunduz, M. Gunduz, L. B. Beder, S. Hirohata, H. Nagatsuka, B. Cengiz, M. Z. Cilek, N. Yamanaka, K. Shimizu and Y. Ninomiya: Increased mRNA expression of ADAMTS metalloproteinases in metastatic foci of head and neck cancer. Head Neck, 31(6), 793-801 (2009)
35. J. Held-Feindt, E. B. Paredes, U. Blomer, C. Seidenbecher, A. M. Stark, H. M. Mehdorn and R. Mentlein: Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer, 118(1), 55-61 (2006) (Pubitemid 41681580)
36. F. Vazquez, G. Hastings, M. A. Ortega, T. F. Lane, S. Oikemus, M. Lombardo and M. L. Iruela-Arispe: METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem, 274(33), 23349-57 (1999)
37. T. Shindo, H. Kurihara, K. Kuno, H. Yokoyama, T. Wada, Y. Kurihara, T. Imai, Y. Wang, M. Ogata, H. Nishimatsu, N. Moriyama, Y. Oh-hashi, H. Morita, T. Ishikawa, R. Nagai, Y. Yazaki and K. Matsushima: ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest, 105(10), 1345-52 (2000) (Pubitemid 30322400)
38. L. Mittaz, D. L. Russell, T. Wilson, M. Brasted, J. Tkalcevic, L. A. Salamonsen, P. J. Hertzog and M. A. Pritchard: Adamts-1 is essential for the development and function of the urogenital system. Biol Reprod, 70(4), 1096-105 (2004) (Pubitemid 38387721)
39. Y. J. Liu, Y. Xu and Q. Yu: Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene, 25(17), 2452-67 (2006)
40. K. Kuno, K. Bannai, M. Hakozaki, K. Matsushima and K. Hirose: The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential. Biochem Biophys Res Commun, 319(4), 1327-33 (2004) (Pubitemid 38759556)
41. G. E. Lind, K. Kleivi, G. I. Meling, M. R. Teixeira, E. Thiis-Evensen, T. O. Rognum and R. A. Lothe: ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol, 28(5-6), 259-72 (2006) (Pubitemid 44950097)
42. A. Luque, D. R. Carpizo and M. L. Iruela-Arispe: ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem, 278(26), 23656-65 (2003) (Pubitemid 36830188)
43. M. Krampert, S. Kuenzle, S. N. M. Thai, N. Lee, M. L. Iruela-Arispe and S. Werner: ADAMTS1 proteinase is upregulated in wounded skin and regulates migration of fibroblasts and endothelial cells. The Journal of Biological Chemistry, 280(25), 23844-52 (2005) (Pubitemid 40884871)
44. N. V. Lee, M. Sato, D. S. Annis, J. a. Loo, L. Wu, D. F. Mosher and M. L. Iruela-Arispe: ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. The EMBO journal, 25(22), 5270-83 (2006) (Pubitemid 44764137)
45. M. L. Iruela-Arispe, D. Carpizo and A. Luque: ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci, 995, 183-90 (2003) (Pubitemid 36706625)
46. Y. J. Lee, M. Koch, D. Karl, A. X. Torres-Collado, N. T. Fernando, C. Rothrock, D. Kuruppu, S. Ryeom, M. L. Iruela-Arispe and S. S. Yoon: Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1. Cancer Res, 70(3), 948-56 (2010)
47. X. Lu, Q. Wang, G. Hu, C. Van Poznak, M. Fleisher, M. Reiss, J. Massague and Y. Kang: ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev, 23(16), 1882-94 (2009)
48. J. C. Rodriguez-Manzaneque, D. Carpizo, C. Plaza-Calonge Mdel, A. X. Torres-Collado, S. N. Thai, M. Simons, A. Horowitz and M. L. Iruela-Arispe: Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion. Int J Biochem Cell Biol, 41(4), 800-10 (2009)
49. C. Esselens, J. Malapeira, N. Colome, C. Casal, J. C. Rodriguez-Manzaneque, F. Canals and J. Arribas: The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration. J Biol Chem, 285(4), 2463-2473 (2010)
50. F. Canals, N. Colome, C. Ferrer, C. Plaza-Calonge Mdel and J. C. Rodriguez-Manzaneque: Identification of substrates of the extracellular protease ADAMTS1 by DIGE proteomic analysis. Proteomics, 6 Suppl 1, S28-35 (2006)
51. A. X. Torres-Collado, W. Kisiel, M. L. Iruela-Arispe and J. C. Rodriguez-Manzaneque: ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2. J Biol Chem, 281(26), 17827-37 (2006) (Pubitemid 44035581)
52. N. V. Lee, J. C. Rodriguez-manzaneque, S. N. M. Thai, W. O. Twal, A. Luque, K. M. Lyons, W. S. Argraves and M. L. Iruela-arispe: Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. The Journal of Biological Chemistry, 280(41), 34796-804 (2005) (Pubitemid 41504613)
53. N. Rocks, G. Paulissen, F. Quesada-Calvo, C. Munaut, M. L. Gonzalez, M. Gueders, J. Hacha, C. Gilles, J. M. Foidart, A. Noel and D. D. Cataldo: ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Research, 68(22), 9541-9550 (2008)
54. C. Casal, A. X. Torres-Collado, C. Plaza-Calonge Mdel, E. Martino-Echarri, Y. C. S. Ramon, F. Rojo, A. W. Griffioen and J. C. Rodriguez-Manzaneque: ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells. Cancer Res, 70(11), 4676-86 (2010)
55. J. R. Dunn, J. E. Reed, D. G. du Plessis, E. J. Shaw, P. Reeves, A. L. Gee, P. Warnke and C. Walker: Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumors. Br J Cancer, 94(8), 1186-93 (2006)
56. J. R. Dunn, D. Panutsopulos, M. W. Shaw, J. Heighway, R. Dormer, E. N. Salmo, S. G. Watson, J. K. Field and T. Liloglou: METH-2 silencing and promoter hypermethylation in NSCLC. British journal of cancer, 91(6), 1149-54 (2004) (Pubitemid 39336255)
57. S. Porter, P. N. Span, F. C. Sweep, V. C. Tjan-Heijnen, C. J. Pennington, T. X. Pedersen, M. Johnsen, L. R. Lund, J. Romer and D. R. Edwards: ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. Int J Cancer, 118(5), 1241-7 (2006) (Pubitemid 43185612)
58. B. H. Koo, D. M. Coe, L. J. Dixon, R. P. Somerville, C. M. Nelson, L. W. Wang, M. E. Young, D. J. Lindner and S. S. Apte: ADAMTS9 is a cell-autonomously acting, antiangiogenic metalloprotease expressed by microvascular endothelial cells. Am J Pathol, 176(3), 1494-504 (2010)
59. M. E. Clark, G. S. Kelner, L. A. Turbeville, A. Boyer, K. C. Arden and R. A. Maki: ADAMTS9, a novel member of the ADAM-TS/ metallospondin gene family. Genomics, 67(3), 343-50 (2000) (Pubitemid 30651033)
60. P. H. Lo, A. C. Leung, C. Y. Kwok, W. S. Cheung, J. M. Ko, L. C. Yang, S. Law, L. D. Wang, J. Li, E. J. Stanbridge, G. Srivastava, J. C. Tang, S. W. Tsao and M. L. Lung: Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene, 26(1), 148-57 (2007) (Pubitemid 46067340)
61. H. L. Lung, P. H. Lo, D. Xie, S. S. Apte, A. K. Cheung, Y. Cheng, E. W. Law, D. Chua, Y. X. Zeng, S. W. Tsao, E. J. Stanbridge and M. L. Lung: Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer, 123(2), 401-8 (2008) (Pubitemid 351842026)
62. J. J. Sheu, C. H. Lee, J. Y. Ko, G. S. Tsao, C. C. Wu, C. Y. Fang, F. J. Tsai, C. H. Hua, C. L. Chen and J. Y. Chen: Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 18(10), 2709-16 (2009)
63. C. J. Liu, W. Kong, K. Xu, Y. Luan, K. Ilalov, B. Sehgal, S. Yu, R. D. Howell and P. E. Di Cesare: ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem, 281(23), 15800-8 (2006) (Pubitemid 43848470)
64. L. Kevorkian, D. a. Young, C. Darrah, S. T. Donell, L. Shepstone, S. Porter, S. M. V. Brockbank, D. R. Edwards, A. E. Parker and I. M. Clark: Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis and rheumatism, 50(1), 131-41 (2004) (Pubitemid 38084297)
65. X. H. Bai, D. W. Wang, Y. Luan, X. P. Yu and C. J. Liu: Regulation of chondrocyte differentiation by ADAMTS-12 metalloproteinase depends on its enzymatic activity. Cell Mol Life Sci, 66(4), 667-80 (2009)
66. M. Llamazares, A. J. Obaya, A. Moncada-Pazos, R. Heljasvaara, J. Espada, C. Lopez-Otin and S. Cal: The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. J Cell Sci, 120(Pt 20), 3544-3552 (2007) (Pubitemid 350120947)
67. A. Moncada-Pazos, A. J. Obaya, M. F. Fraga, C. G. Viloria, G. Capella, M. Gausachs, M. Esteller, C. Lopez-Otin and S. Cal: The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci, 122(Pt 16), 2906-13 (2009)
68. M. El Hour, A. Moncada-Pazos, S. Blacher, A. Masset, S. Cal, S. Berndt, J. Detilleux, L. Host, A. J. Obaya, C. Maillard, J. M. Foidart, F. Ectors, A. Noel and C. Lopez-Otin: Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis. Oncogene, 29(20), 3025-32 (2010)
69. L. Oleksowicz, N. Bhagwati and M. DeLeon- Fernandez: Deficient activity of von Willebrand's factorcleaving protease in patients with disseminated malignancies. Cancer Res, 59(9), 2244-50 (1999) (Pubitemid 29217692)
70. B. H. Koo, D. Oh, S. Y. Chung, N. K. Kim, S. Park, Y. Jang and K. H. Chung: Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients. Thromb Res, 105(6), 471-6 (2002) (Pubitemid 34686905)
71. P. M. Mannucci, M. Vanoli, I. Forza, M. T. Canciani and R. Scorza: Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica, 88(8), 914-8 (2003) (Pubitemid 37128091)
72. M. Bohm, R. Gerlach, W. D. Beecken, T. Scheuer, I. Stier-Bruck and I. Scharrer: ADAMTS-13 activity in patients with brain and prostate tumors is mildly reduced, but not correlated to stage of malignancy and metastasis. Thromb Res, 111(1-2), 33-7 (2003) (Pubitemid 37485923)
73. G. C. Jones, A. N. Corps, C. J. Pennington, I. M. Clark, D. R. Edwards, M. M. Bradley, B. L. Hazleman and G. P. Riley: Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis and rheumatism, 54(3), 832-42 (2006)
74. S. Jones, X. Zhang, D. W. Parsons, J. C. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, S. M. Hong, B. Fu, M. T. Lin, E. S. Calhoun, M. Kamiyama, K. Walter, T. Nikolskaya, Y. Nikolsky, J. Hartigan, D. R. Smith, M. Hidalgo, S. D. Leach, A. P. Klein, E. M. Jaffee, M. Goggins, A. Maitra, C. Iacobuzio-Donahue, J. R. Eshleman, S. E. Kern, R. H. Hruban, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu and K. W. Kinzler: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321(5897), 1801-6 (2008)
75. C. G. Viloria, A. J. Obaya, A. Moncada-Pazos, M. Llamazares, A. Astudillo, G. Capellá, S. Cal and C. López-Otín: Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Research, 69(11), 4926-34 (2009)
76. H. Jin, X. Wang, J. Ying, a. H. Y. Wong, H. Li, K. Y. Lee, G. Srivastava, a. T. C. Chan, W. Yeo, B. B. Y. Ma, T. C. Putti, M. L. Lung, Z. Y. Shen, L. Y. Xu, C. Langford and Q. Tao: Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene, 26(53), 7490-8 (2007) (Pubitemid 350158717)
77. Z. Li, M. A. Nardi, Y. S. Li, W. Zhang, R. Pan, S. Dang, H. Yee, D. Quartermain, S. Jonas and S. Karpatkin: Cterminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke. Blood, 113(24), 6051-60 (2009)
78. S. Sharghi-Namini, H. Fan, K. N. Sulochana, P. Potturi, W. Xiang, Y. S. Chong, Z. Wang, H. Yang and R. Ge: The first but not the second thrombospondin type 1 repeat of ADAMTS5 functions as an angiogenesis inhibitor. Biochem Biophys Res Commun, 371(2), 215-9 (2008)
79. C. M. Overall and C. P. Blobel: In search of partners: linking extracellular proteases to substrates. Nature reviews. Molecular cell biology, 8(3), 245-57 (2007)